Jio Platforms Is Subscribed 2.36x. What That Tells Long-Term Investors.
The real question isn’t the IPO. It’s whether your India and Reliance exposure is priced for what comes next.
The world could quit tobacco. It cannot quit controlling pests.
A note from our friends at Med-X Inc(ad) National Investor Network Special Situation Letter A Private Message for Independent Investors…
GSK’s Jemperli Just Got a First-and-Only Label. Is the Stock Finally Worth Buying?
A surgery-sparing FDA approval gives GSK its most compelling oncology story in years, but the stock’s discount to peers tells a complicated tale.
Elon Musk’s Next Partnership: Buy This Stock Now
October 20, 2026 Bonus Content: If Iran’s Hormuz Deal Works, Brent Falls Hard. Here’s Who Gets Hurt First. A note…
Trump Waived the Russia Tariffs He Signed. What It Means for Oil and Defence Shares.
Putin wants a summit without Zelensky, Trump is pausing his own Russia law, and the uncertainty is moving Brent and defence stocks.
Chubb Reports Tonight With Profit Expected Down 17%
CB is up about 5% in a week heading into Tuesday’s release, leaving little cushion if catastrophe losses or the accident-year ratio disappoint.
Don’t pay later for what’s free now
October 19, 2026 Bonus Content: France Heads Into Tuesday’s Budget Vote With Burned City Halls and a €340bn Borrowing Bill…
SoftBank Wants to Own the Guards It Plans to Replace With Robots
Masayoshi Son’s reported $18 billion bid for Allied Universal is less a security play than a blueprint for automating America’s largest human workforce.
The Russell 2000 Is in Correction. The Dow’s Gain Hides Why.
Three indexes moved three directions last week. The loudest rate signal came from the one that fell hardest.
Undiscovered Sub-$1 Gold-Silver Royalty Stock Takes Flight
A note from our friends at Resource Stock Digest(ad) Gold and silver are in a powerful bull market – and…